Company Profile

UroCor Inc (AKA: Cytodiagnostics Inc)
Profile last edited on: 5/10/2017      CAGE: 1JPU1      UEI: PJLLKR51QEA5

Business Identifier: Disease management services for urology
Year Founded
1988
First Award
1992
Latest Award
2001
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

840 Research Parkway
Oklahoma City, OK 73104
   (405) 290-4000
   N/A
   www.urocor.com
Location: Multiple
Congr. District: 05
County: Oklahoma

Public Profile

Previously doing business as CytoDiagnostics), in November 2001 DIANON Systems, Inc. acquired UroCor Inc. UroCor is a Disease Management Organization (DMO) in urology. The firm markets a comprehensive range of integrated products and services to assist in detecting, diagnosing, treating and managing prostate cancer, bladder cancer, kidney stones and other complex urologic disorders directly to urologists and managed care organizations. UroCor's primary focus is helping urologists improve patient care and outcomes, while reducing the total cost of managing these diseases.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
500+
Revenue Range
Over 50M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : UCOR
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2001 1 NIH $97,627
Project Title: Methylation Specific PCR For Cancer Diagnosis/Prognosis
2001 2 NIH $793,828
Project Title: P53 Mutational Analysis For Bladder Cancer Prognosis
1999 1 NIH $99,618
Project Title: Prostate Cancer Diagnosis with Multiplex RT PCR
1998 1 NIH $81,255
Project Title: Diagnostic Soluble Urine Test For Interstitial Cystitis
1993 1 NIH $49,935
Project Title: In vitro low shear three dimensional bladder tumor model

Key People / Management

  Kevin Johnson -- President

  Gang An

  Garry M Marley

  David A Ralph

Company News

There are no news available.